KR102844018B1 - N-알킬 아미노산, 및 n-알킬 아미노산을 포함하는 펩타이드의 제조 방법 - Google Patents
N-알킬 아미노산, 및 n-알킬 아미노산을 포함하는 펩타이드의 제조 방법Info
- Publication number
- KR102844018B1 KR102844018B1 KR1020247023000A KR20247023000A KR102844018B1 KR 102844018 B1 KR102844018 B1 KR 102844018B1 KR 1020247023000 A KR1020247023000 A KR 1020247023000A KR 20247023000 A KR20247023000 A KR 20247023000A KR 102844018 B1 KR102844018 B1 KR 102844018B1
- Authority
- KR
- South Korea
- Prior art keywords
- ester
- amino acid
- group
- peptide
- paragraph
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B61/00—Other general methods
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C227/14—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof
- C07C227/18—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof by reactions involving amino or carboxyl groups, e.g. hydrolysis of esters or amides, by formation of halides, salts or esters
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/02—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length in solution
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/06—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents
- C07K1/061—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents using protecting groups
- C07K1/062—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents using protecting groups for alpha- or omega-carboxy functions
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/50—Cyclic peptides containing at least one abnormal peptide link
- C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
- C07K7/56—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/64—Cyclic peptides containing only normal peptide links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Analytical Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Peptides Or Proteins (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021214900 | 2021-12-28 | ||
| JPJP-P-2021-214900 | 2021-12-28 | ||
| JP2022168608 | 2022-10-20 | ||
| JPJP-P-2022-168608 | 2022-10-20 | ||
| PCT/JP2022/048135 WO2023127869A1 (ja) | 2021-12-28 | 2022-12-27 | Ｎ－アルキルアミノ酸、およびｎ－アルキルアミノ酸を含むペプチドの製造方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| KR20240113971A KR20240113971A (ko) | 2024-07-23 |
| KR102844018B1 true KR102844018B1 (ko) | 2025-08-07 |
Family
ID=86999039
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020247023000A Active KR102844018B1 (ko) | 2021-12-28 | 2022-12-27 | N-알킬 아미노산, 및 n-알킬 아미노산을 포함하는 펩타이드의 제조 방법 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20250197450A1 (https=) |
| EP (1) | EP4414374A4 (https=) |
| JP (2) | JP7430297B2 (https=) |
| KR (1) | KR102844018B1 (https=) |
| AR (1) | AR128119A1 (https=) |
| AU (1) | AU2022428318A1 (https=) |
| CA (1) | CA3237911A1 (https=) |
| IL (1) | IL312468A (https=) |
| MX (1) | MX2024008002A (https=) |
| TW (1) | TW202342495A (https=) |
| WO (1) | WO2023127869A1 (https=) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI787670B (zh) | 2011-12-28 | 2022-12-21 | 日商中外製藥股份有限公司 | 具有環狀部之胜肽化合物及其醫藥組成物 |
| WO2018225851A1 (ja) | 2017-06-09 | 2018-12-13 | 中外製薬株式会社 | Ｎ－置換アミノ酸を含むペプチドの合成方法 |
| EP3878836B1 (en) | 2018-11-07 | 2025-07-23 | Chugai Seiyaku Kabushiki Kaisha | O-substituted serine derivative production method |
| PE20221323A1 (es) | 2019-11-07 | 2022-09-09 | Chugai Pharmaceutical Co Ltd | Compuesto de peptidos ciclicos que tiene accion inhibidora de kras |
| TW202309065A (zh) | 2021-05-07 | 2023-03-01 | 日商中外製藥股份有限公司 | 包含n-取代胺基酸殘基之環狀化合物的製造方法 |
| CA3256645A1 (en) | 2022-05-06 | 2025-04-23 | Chugai Seiyaku Kabushiki Kaisha | CYCLIC COMPOUND HAVING A SELECTIVE KRAS INHIBITORY EFFECT ON HRAS AND NRAS |
| EP4596567A1 (en) | 2022-11-01 | 2025-08-06 | Chugai Seiyaku Kabushiki Kaisha | Method for removing dibenzofulvene or dibenzofulvene derivative |
| JPWO2024143514A1 (https=) | 2022-12-28 | 2024-07-04 | ||
| WO2025070753A1 (ja) | 2023-09-28 | 2025-04-03 | 中外製薬株式会社 | 混合酸無水物法を用いたペプチド化合物の製造方法 |
| CN121889409A (zh) | 2023-12-27 | 2026-04-17 | 中外制药株式会社 | 用于使用独立型缩合剂生产肽化合物的方法 |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000015656A1 (en) | 1998-09-10 | 2000-03-23 | Holland Sweetener Company V.O.F. | Process for the preparation of neotame |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7232758B2 (ja) | 2017-06-09 | 2023-03-06 | 中外製薬株式会社 | 膜透過性の高い環状ペプチド化合物、及びこれを含むライブラリ |
| WO2018225851A1 (ja) * | 2017-06-09 | 2018-12-13 | 中外製薬株式会社 | Ｎ－置換アミノ酸を含むペプチドの合成方法 |
| JP7568510B2 (ja) * | 2018-11-30 | 2024-10-16 | 中外製薬株式会社 | ペプチド化合物、またはアミド化合物の脱保護法および固相反応における脱樹脂方法、並びにペプチド化合物の製造方法 |
| WO2020122182A1 (ja) | 2018-12-12 | 2020-06-18 | 中外製薬株式会社 | 分子内水素結合可能な官能基を有するアミノ酸とそれらのアミノ酸を含むペプチド化合物、およびそれらの製造方法 |
| KR20210139366A (ko) | 2019-03-15 | 2021-11-22 | 추가이 세이야쿠 가부시키가이샤 | 방향족 아미노산 유도체의 제조 방법 |
| PE20221323A1 (es) * | 2019-11-07 | 2022-09-09 | Chugai Pharmaceutical Co Ltd | Compuesto de peptidos ciclicos que tiene accion inhibidora de kras |
-
2022
- 2022-12-27 MX MX2024008002A patent/MX2024008002A/es unknown
- 2022-12-27 EP EP22916092.4A patent/EP4414374A4/en active Pending
- 2022-12-27 CA CA3237911A patent/CA3237911A1/en active Pending
- 2022-12-27 AR ARP220103601A patent/AR128119A1/es unknown
- 2022-12-27 KR KR1020247023000A patent/KR102844018B1/ko active Active
- 2022-12-27 WO PCT/JP2022/048135 patent/WO2023127869A1/ja not_active Ceased
- 2022-12-27 AU AU2022428318A patent/AU2022428318A1/en active Pending
- 2022-12-27 US US18/723,993 patent/US20250197450A1/en active Pending
- 2022-12-27 TW TW111150100A patent/TW202342495A/zh unknown
- 2022-12-27 JP JP2023568520A patent/JP7430297B2/ja active Active
- 2022-12-27 IL IL312468A patent/IL312468A/en unknown
-
2024
- 2024-01-30 JP JP2024011686A patent/JP2024052694A/ja active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000015656A1 (en) | 1998-09-10 | 2000-03-23 | Holland Sweetener Company V.O.F. | Process for the preparation of neotame |
Also Published As
| Publication number | Publication date |
|---|---|
| KR20240113971A (ko) | 2024-07-23 |
| EP4414374A1 (en) | 2024-08-14 |
| JPWO2023127869A1 (https=) | 2023-07-06 |
| IL312468A (en) | 2024-06-01 |
| WO2023127869A1 (ja) | 2023-07-06 |
| JP2024052694A (ja) | 2024-04-11 |
| AR128119A1 (es) | 2024-03-27 |
| EP4414374A4 (en) | 2025-11-19 |
| JP7430297B2 (ja) | 2024-02-09 |
| TW202342495A (zh) | 2023-11-01 |
| US20250197450A1 (en) | 2025-06-19 |
| CA3237911A1 (en) | 2023-07-06 |
| MX2024008002A (es) | 2024-07-12 |
| AU2022428318A1 (en) | 2024-05-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR102844018B1 (ko) | N-알킬 아미노산, 및 n-알킬 아미노산을 포함하는 펩타이드의 제조 방법 | |
| US12312379B2 (en) | Methods for producing cyclic compounds comprising N-substituted amino acid residues | |
| TWI850887B (zh) | 具有Kras抑制作用的環狀胜肽化合物 | |
| EP4162954A1 (en) | Camptothecin drug having high-stability hydrophilic connecting unit and conjugate thereof | |
| CN103649051B (zh) | 制备包括反-7-氧代-6-(磺基氧基)-1,6-二氮杂二环[3,2,1]辛烷-2-甲酰胺的杂环化合物及其盐的方法 | |
| TW202309064A (zh) | 環狀胜肽化合物的醫藥用途 | |
| TW202406927A (zh) | 相對於ｈｒａｓ與ｎｒａｓ具有選擇性之ｋｒａｓ抑制作用的環狀化合物 | |
| KR20230019120A (ko) | 고난도 서열의 효율적 펩티드 축합법 | |
| CN115175734A (zh) | 作为免疫调节剂的吡啶并[3,2-d]嘧啶化合物 | |
| CN114829366A (zh) | Pd-1/pd-l1抑制剂的盐及结晶形式 | |
| TWI558706B (zh) | A tricyclic compound and a tricyclic compound which can be produced by the production method | |
| HK40108253A (zh) | N-烷基氨基酸以及包含n-烷基氨基酸的肽的制造方法 | |
| CN118475590A (zh) | N-烷基氨基酸以及包含n-烷基氨基酸的肽的制造方法 | |
| KR102569348B1 (ko) | N-치환 아미노산 잔기를 포함하는 환상 화합물의 제조 방법 | |
| HK40096738A (zh) | 包含n-取代氨基酸残基的环状化合物的制备方法 | |
| HK40080071A (en) | Efficient peptide condensation method for difficult sequences | |
| HK40083545A (en) | Camptothecin drug having high-stability hydrophilic connecting unit and conjugate thereof | |
| TW202535901A (zh) | 使用獨立型縮合劑的胜肽化合物的製造方法 | |
| CN121941697A (zh) | 用于使用两种或更多种添加剂生产肽化合物的方法 | |
| US20260001882A1 (en) | Process for preparing bicyclic glycine-proline compounds and monocyclic glycine-proline intermediates thereof | |
| HK40117546A (zh) | 用於生产o-取代的丝氨酸衍生物的方法 | |
| WO2011090316A2 (ko) | 세포사멸 유도 활성을 갖는 신규 피라지논 유도체 및 이를 포함하는 약학 조성물 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A201 | Request for examination | ||
| A302 | Request for accelerated examination | ||
| P11-X000 | Amendment of application requested |
St.27 status event code: A-2-2-P10-P11-nap-X000 |
|
| P13-X000 | Application amended |
St.27 status event code: A-2-2-P10-P13-nap-X000 |
|
| PA0105 | International application |
St.27 status event code: A-0-1-A10-A15-nap-PA0105 |
|
| PA0201 | Request for examination |
St.27 status event code: A-1-2-D10-D11-exm-PA0201 |
|
| PA0302 | Request for accelerated examination |
St.27 status event code: A-1-2-D10-D17-exm-PA0302 St.27 status event code: A-1-2-D10-D16-exm-PA0302 |
|
| PG1501 | Laying open of application |
St.27 status event code: A-1-1-Q10-Q12-nap-PG1501 |
|
| E902 | Notification of reason for refusal | ||
| PE0902 | Notice of grounds for rejection |
St.27 status event code: A-1-2-D10-D21-exm-PE0902 |
|
| E13-X000 | Pre-grant limitation requested |
St.27 status event code: A-2-3-E10-E13-lim-X000 |
|
| P11-X000 | Amendment of application requested |
St.27 status event code: A-2-2-P10-P11-nap-X000 |
|
| R18-X000 | Changes to party contact information recorded |
St.27 status event code: A-3-3-R10-R18-oth-X000 |
|
| E701 | Decision to grant or registration of patent right | ||
| PE0701 | Decision of registration |
St.27 status event code: A-1-2-D10-D22-exm-PE0701 |
|
| F11 | Ip right granted following substantive examination |
Free format text: ST27 STATUS EVENT CODE: A-2-4-F10-F11-EXM-PR0701 (AS PROVIDED BY THE NATIONAL OFFICE) |
|
| PR0701 | Registration of establishment |
St.27 status event code: A-2-4-F10-F11-exm-PR0701 |
|
| PR1002 | Payment of registration fee |
St.27 status event code: A-2-2-U10-U12-oth-PR1002 Fee payment year number: 1 |
|
| U12 | Designation fee paid |
Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U12-OTH-PR1002 (AS PROVIDED BY THE NATIONAL OFFICE) Year of fee payment: 1 |
|
| PG1601 | Publication of registration |
St.27 status event code: A-4-4-Q10-Q13-nap-PG1601 |
|
| Q13 | Ip right document published |
Free format text: ST27 STATUS EVENT CODE: A-4-4-Q10-Q13-NAP-PG1601 (AS PROVIDED BY THE NATIONAL OFFICE) |